ArticleBMC infectious diseases2023

Clinical experience of treatment of immunocompromised individuals with persistent SARS-CoV-2 infection based on drug resistance mutations determined by genomic analysis: a descriptive study.

Haruka Shimazu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.